Vol. 22, Issue 1, 2014January 01, 2014 EDT
Trade Secret Rising: Protecting Equivalency Test Research and Development Investments After Momenta v. Amphastar
Trade Secret Rising: Protecting Equivalency Test Research and Development Investments After Momenta v. Amphastar
Hannah-Alise Rogers,
patentHatch-Waxman ActFood and Drug AdministrationFDAsafe harbortrade secretFOIAAbbreviated New Drug ApplicationANDAUniform Trade Secrets ActUTSAdrug manufacturersgeneric manufacturerspharmaceuticalbioequivalency test; Momenta v. Amphastar
Hannah-Alise Rogers, Trade Secret Rising: Protecting Equivalency Test Research and Development Investments After Momenta v. Amphastar, 22 Journal of Intellectual Property 209 (2014).